CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to combat antibiotic resistance by developing hydrogels that release bacteria-derived vesicles with antimicrobial properties in response to specific pathogens. This targeted approach seeks to minimize side effects and enhance the effectiveness of treatments for bacterial infections.
The rise of bacterial resistance against antibiotic drugs is becoming the leading cause for morbidity and mortality worldwide.
In Europe alone, up to 33,000 people die each year from infections with resistant bacteria.
Current antibiotic therapy often suffers from low selectivity, adverse side effects in other organs and impaired ability to overcome bacterial barriers.
These problems limit the efficacy of our antibiotic arsenal.
Local and effective eradication of bacterial infections is of utmos…
FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN-NUERNBERG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
